Pertuzumab: a new anti-HER2 drug in the management of women with breast cancer.
about
Individualized treatment of gastric cancer: Impact of molecular biology and pathohistological featuresTwenty years of anti-HER2 therapy-associated cardiotoxicityMechanisms of action of therapeutic antibodies for cancerMulti-parametric analysis reveals enhanced G2-phase arrest of an optimized anti-HER2 antibody to inhibit breast cancer.Understanding preanalytical variables and their effects on clinical biomarkers of oncology and immunotherapy.Metastatic and triple-negative breast cancer: challenges and treatment options
P2860
Pertuzumab: a new anti-HER2 drug in the management of women with breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Pertuzumab: a new anti-HER2 drug in the management of women with breast cancer.
@en
type
label
Pertuzumab: a new anti-HER2 drug in the management of women with breast cancer.
@en
prefLabel
Pertuzumab: a new anti-HER2 drug in the management of women with breast cancer.
@en
P2860
P356
P1433
P1476
Pertuzumab: a new anti-HER2 drug in the management of women with breast cancer.
@en
P2093
Bhawna Sirohi
Shaheenah Dawood
P2860
P304
P356
10.2217/FON.15.7
P407
P577
2015-03-01T00:00:00Z